We are live on ! Find out more
HPTX

HYPERION THERAPEUTICS INC COM STK (DE)
HPTX

Delisted

HPTX was delisted on the 7th of May, 2015.

97 hedge funds and large institutions have $398M invested in HYPERION THERAPEUTICS INC COM STK (DE) in 2014 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 13

52% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 23

8% more funds holding

Funds holding: 9097 (+7)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

4% less capital invested

Capital invested by funds: $413M → $398M (-$15.7M)

Holders
97
Holders Change
+7
Holders Change %
+7.78%
% of All Funds
2.81%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.12%
New
20
Increased
35
Reduced
23
Closed
13
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
JP Morgan Chase
51
JP Morgan Chase
New York
$628K -$1.96K -79 -0.3%
CCM
52
Cadence Capital Management
Massachusetts
$556K +$547K +22,030 New
TA
53
Teachers Advisors
New York
$502K +$22.6K +909 +5%
SCA
54
Secor Capital Advisors
New York
$467K +$460K +18,516 New
GAM
55
Gotham Asset Management
New York
$457K +$450K +18,109 New
DC
56
Deere & Company
Illinois
$448K -$78.9K -3,179 -15%
SIM
57
Spark Investment Management
New York
$446K -$151K -6,100 -26%
VRS
58
Virginia Retirement Systems
Virginia
$315K
PNC Financial Services Group
59
PNC Financial Services Group
Pennsylvania
$314K
PAM
60
Panagora Asset Management
Massachusetts
$311K +$306K +12,333 New
RhumbLine Advisers
61
RhumbLine Advisers
Massachusetts
$300K -$3.48K -140 -1%
NCCM
62
Nine Chapters Capital Management
New Jersey
$285K +$281K +11,300 New
MLICM
63
Metropolitan Life Insurance Company (MetLife)
New York
$276K
AQR Capital Management
64
AQR Capital Management
Connecticut
$263K
AL
65
Airain Ltd
Guernsey
$258K +$25.3K +1,019 +11%
Goldman Sachs
66
Goldman Sachs
New York
$244K +$241K +9,691 New
Bank of America
67
Bank of America
North Carolina
$234K +$195K +7,867 +562%
AIG
68
American International Group
New York
$224K -$149 -6 -0.1%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$215K
Connor, Clark & Lunn Investment Management (CC&L)
70
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$212K +$209K +8,400 New
MAM
71
Martingale Asset Management
Massachusetts
$210K +$206K +8,309 New
PCM
72
Prelude Capital Management
New York
$179K +$29.8K +1,200 +20%
Swiss National Bank
73
Swiss National Bank
Switzerland
$174K
U
74
UBS
Switzerland
$100K +$82.1K +3,307 +493%
RFC
75
Russell Frank Company
Washington
$96K +$37.1K +1,495 +64%

HPTX Hedge Fund Activity: Q3 2014 in Review

97 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) for Q3 2014, worth a combined $398M — down 3.8% from $413M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new HPTX positions and 13 closed out — a net gain of 7 holders — while 35 added to existing stakes and 23 trimmed.

The largest buyer was Great Point Partners, adding an estimated $3.37M. The largest seller was Fidelity Investments, cutting an estimated $15.3M.

  • 97 institutional investors held HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) as of Q3 2014, up from 90 in Q2 2014.
  • Funds reported $398M of HYPERION THERAPEUTICS INC COM STK (DE) stock for Q3 2014, down 3.8% quarter-over-quarter.
  • 20 funds opened new HYPERION THERAPEUTICS INC COM STK (DE) positions in Q3 2014 and 13 closed out, a net change of +7 holders.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) buyer in Q3 2014 was Great Point Partners, an estimated $3.37M added.
  • The largest HYPERION THERAPEUTICS INC COM STK (DE) seller in Q3 2014 was Fidelity Investments, an estimated $15.3M sold.

Based on aggregated 13F filings for Q3 2014.